[1]Jacquier;Christol[BulletindelaSocieteChimiquedeFrance,1957,p.600,606]
[1]CurrentPatentAssignee:BELLUSHEALTHINC.-US2006/223855,2006,A1Locationinpatent:Page/Pagecolumn151-152
[2]Kotschetkowetal.[ZhurnalObshcheiKhimii,1959,vol.29,p.3620,3622;engl.Ausg.S.3581,3583]
[1]Yukawa;Tanaka[MemoirsoftheInstituteofScientificandIndustrialResearch,OsakaUniversity,1957,vol.14,p.199,201]
[1]DeLuca,Lidia;Giacomelli,Giampaolo;Porcheddu,Andrea[OrganicLetters,2002,vol.4,#4,p.553-555]
[2]Hurd;Jones[JournaloftheAmericanChemicalSociety,1934,vol.56,p.1924,1925]
[3]Bucketal.[JournaloftheInstituteofPetroleum,1948,vol.34,p.350][Chem.Abstr.,1948,p.7012]
[4]Arumugam,N.etal.[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1978,vol.16,p.917-920]
[5]Locationinpatent:schemeortableHullio,AhmedAli;Mastoi[ChineseJournalofChemistry,2012,vol.30,#7,p.1647-1657]
[6]Venkana,Purugula;Kumar,MukkaSatish;Rajanna,KamatalaChinna;Ali,MirMoazzam[SynthesisandReactivityinInorganic,Metal-Organic,andNano-MetalChemistry,2015,vol.45,#1,p.97-103]
[1]Koch;Haaf[JustusLiebigsAnnalenderChemie,1958,vol.618,p.251,261]
Title: Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.
Journal: Molecular neurodegeneration 20100101
Title: Venlafaxine extended release (XR) in the treatment of panic disorder.
Journal: Therapeutics and clinical risk management 20070301
Title: Venlafaxine in the treatment of panic disorder.
Journal: Neuropsychiatric disease and treatment 20070201